Metabolic reprogramming in the tumor microenvironment: unleashing T cell stemness for enhanced cancer immunotherapy
Tumor microenvironment-induced T cell stemness. (A) High K+ levels in the tumor microenvironment promote T cell stemness. High K+ leads to an increase in AcCoA within mitochondria while decreasing it in the nucleus, inducing autophagy and histone hypoacetylation. These alterations in gene expression reduce T cell differentiation into effector T cells by inhibiting the TCR signaling pathway. The inhibition of TCR by high K+ primarily occurs through reduced phosphorylation of Akt-targeted serine/threonine residues upon TCR activation. (B) Elevated lactate in the tumor microenvironment induces T cell stemness by increasing acetylation levels at the H3K27 locus within the TCF-1 gene during CD8+ T cell differentiation. This elevated acetylation preserves cellular stemness. (C) T cell stemness induced by high H+ levels in the tumor microenvironment. Elevated FAO results in increased AcCoA levels, leading to TCR inhibition, reduced T cell activation, and inhibition of methionine synthase MTR, thereby decreasing methionine synthesis. This reduction further lowers the synthesis of SAM and S-adenosylhomocysteine (SAH). SAM is a critical methyl donor for DNA and histone methylation reactions. The decreased methylation levels, particularly the histone marker H3K27me3, enhance TCF-1 expression.
Publication
Metabolic reprogramming in the tumor microenvironment: unleashing T cell stemness for enhanced cancer immunotherapy. (2023) Youhan Liu, et al. Front Pharmacol. 2023;14:1327717. Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CA | 5290 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CB | 5291 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CD | 5293 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CG | 5294 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R3 | 8503 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R4 | 30849 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R5 | 23533 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R6 | 146850 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R1 | 5295 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R2 | 5296 |
| Homo sapiens | Primates | MTR | MTR | ncbigene_symbol | MTR | 4548 |
| Homo sapiens | Primates | BHMT | BHMT | ncbigene_symbol | BHMT | 635 |
| Homo sapiens | Primates | SAH | SAH | ncbigene_synonym | ACSM3 | 6296 |
| Homo sapiens | Primates | TCF-11 | TCF11 | ncbigene_synonym | NFE2L1 | 4779 |
| Homo sapiens | Primates | mTOR | MTOR | ncbigene_symbol | MTOR | 2475 |
| Danio rerio | Vertebrates | MTR | MTR | ncbigene_symbol | mtr | 378847 |
| Danio rerio | Vertebrates | BHMT | BHMT | ncbigene_symbol | bhmt | 322228 |
| Danio rerio | Vertebrates | mTOR | MTOR | ncbigene_symbol | mtor | 324254 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Lactate | lactate | lactate | chebi:24996 | |
| Lactate | lactate | lactate | chebi:24996 | |
| Citrate | citrate | chebi:133748 | ||
| Glucose | Glucose | aldehydo-D-glucose | chebi:42758 | |
| Pyruvate | pyruvate | pyruvate | chebi:15361 | |
| Homocysteine | homocysteine | homocysteine | chebi:17230 | |
| Betaine | Betaine | (trimethylammonio)acetate | chebi:17750 | |
| Methionine | Methionine | L-methionine | chebi:16643 | |
| SAH | SAH | S-(5'-deoxyadenosin-5'-yl)-L-homocysteine | chebi:16680 | |
| Citrate | citrate | chebi:133748 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|